Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214578045> ?p ?o ?g. }
- W4214578045 endingPage "560" @default.
- W4214578045 startingPage "553" @default.
- W4214578045 abstract "We aim to study the association between stromal tumor infiltrating lymphocytes (TILs) level and disease free survival (DFS) in a group of ER and PR negative, HER2+ locally advanced breast cancer patients who underwent curative intent surgery.This is a retrospective cohort study including 66 locally advanced hormone receptor-negative; HER2+ breast cancer patients presented between 2013 and 2015 at NCI-Cairo, Egypt. Enrolled patients had at least clinically T3 and/or node positive disease either clinically or radiologically. Metastatic workup included CT and bone scans or PET-CT. Patients with hormone receptor positive, HER2 negative, inadequate paraffin block and who lost follow up before or immediately after curative surgery were excluded. Patients were followed from breast surgery till relapse date for a minimum of 36 months. TILs and CD8 antigen were assessed on paraffin-embedded blocks using immunohistochemistry.Patients with a median age of 52 years presented with clinical T3 stage (53%) and N1 stage (61%). Modified radical mastectomy was performed in 79%. Only 41% received neoadjuvant chemotherapy and 56% received trastuzumab. TILs were 50, 17 and 33% for absent, intermediate and extensive groups and CD8+ lymphocytes were present in 80% of cases. At the end of follow-up period, 23 patients (35%) were found to have disease recurrence either loco-regional (22%) or distant (78%). TILs were 14, 4 and 5% for absent, intermediate and extensive respectively; while CD8+ lymphocytes were absent in 6% and present (≥1%) in 17%. Higher DFS was recorded for patients with extensive TILs level only who received trastuzumab.High TILs is good prognosis in HER2 enriched breast cancer provided that patients received HER2 directed therapy. Moreover, CD8+ lymphocytes are highly representative and maybe used as an alternative for TILs. We recommend considering TILs and specifically CD8+ as one of the risk factors that predict prognosis of HER2+ breast cancer." @default.
- W4214578045 created "2022-03-02" @default.
- W4214578045 creator A5016107571 @default.
- W4214578045 creator A5031340998 @default.
- W4214578045 creator A5049034273 @default.
- W4214578045 creator A5055030515 @default.
- W4214578045 creator A5069213672 @default.
- W4214578045 creator A5091257362 @default.
- W4214578045 date "2022-02-01" @default.
- W4214578045 modified "2023-09-27" @default.
- W4214578045 title "Prognostic Value of Tumor Infiltrating Lymphocytes in Locally Advanced HER2 Enriched Breast Cancer" @default.
- W4214578045 cites W1836115854 @default.
- W4214578045 cites W2010871781 @default.
- W4214578045 cites W2096145980 @default.
- W4214578045 cites W2098683355 @default.
- W4214578045 cites W2107380545 @default.
- W4214578045 cites W2120338564 @default.
- W4214578045 cites W2120431466 @default.
- W4214578045 cites W2148154454 @default.
- W4214578045 cites W2157058802 @default.
- W4214578045 cites W2159427817 @default.
- W4214578045 cites W2298279588 @default.
- W4214578045 cites W2313168486 @default.
- W4214578045 cites W2407664560 @default.
- W4214578045 cites W2560367415 @default.
- W4214578045 cites W2605189410 @default.
- W4214578045 cites W2783304102 @default.
- W4214578045 cites W2912357784 @default.
- W4214578045 cites W3006134372 @default.
- W4214578045 cites W3006138035 @default.
- W4214578045 cites W3018818368 @default.
- W4214578045 cites W3044945681 @default.
- W4214578045 doi "https://doi.org/10.31557/apjcp.2022.23.2.553" @default.
- W4214578045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35225468" @default.
- W4214578045 hasPublicationYear "2022" @default.
- W4214578045 type Work @default.
- W4214578045 citedByCount "0" @default.
- W4214578045 crossrefType "journal-article" @default.
- W4214578045 hasAuthorship W4214578045A5016107571 @default.
- W4214578045 hasAuthorship W4214578045A5031340998 @default.
- W4214578045 hasAuthorship W4214578045A5049034273 @default.
- W4214578045 hasAuthorship W4214578045A5055030515 @default.
- W4214578045 hasAuthorship W4214578045A5069213672 @default.
- W4214578045 hasAuthorship W4214578045A5091257362 @default.
- W4214578045 hasBestOaLocation W42145780451 @default.
- W4214578045 hasConcept C121608353 @default.
- W4214578045 hasConcept C126322002 @default.
- W4214578045 hasConcept C143998085 @default.
- W4214578045 hasConcept C146357865 @default.
- W4214578045 hasConcept C151730666 @default.
- W4214578045 hasConcept C167135981 @default.
- W4214578045 hasConcept C204232928 @default.
- W4214578045 hasConcept C2776694085 @default.
- W4214578045 hasConcept C2777701055 @default.
- W4214578045 hasConcept C2777757722 @default.
- W4214578045 hasConcept C2778311097 @default.
- W4214578045 hasConcept C2778326572 @default.
- W4214578045 hasConcept C2779786085 @default.
- W4214578045 hasConcept C2910733956 @default.
- W4214578045 hasConcept C530470458 @default.
- W4214578045 hasConcept C71924100 @default.
- W4214578045 hasConcept C86803240 @default.
- W4214578045 hasConceptScore W4214578045C121608353 @default.
- W4214578045 hasConceptScore W4214578045C126322002 @default.
- W4214578045 hasConceptScore W4214578045C143998085 @default.
- W4214578045 hasConceptScore W4214578045C146357865 @default.
- W4214578045 hasConceptScore W4214578045C151730666 @default.
- W4214578045 hasConceptScore W4214578045C167135981 @default.
- W4214578045 hasConceptScore W4214578045C204232928 @default.
- W4214578045 hasConceptScore W4214578045C2776694085 @default.
- W4214578045 hasConceptScore W4214578045C2777701055 @default.
- W4214578045 hasConceptScore W4214578045C2777757722 @default.
- W4214578045 hasConceptScore W4214578045C2778311097 @default.
- W4214578045 hasConceptScore W4214578045C2778326572 @default.
- W4214578045 hasConceptScore W4214578045C2779786085 @default.
- W4214578045 hasConceptScore W4214578045C2910733956 @default.
- W4214578045 hasConceptScore W4214578045C530470458 @default.
- W4214578045 hasConceptScore W4214578045C71924100 @default.
- W4214578045 hasConceptScore W4214578045C86803240 @default.
- W4214578045 hasIssue "2" @default.
- W4214578045 hasLocation W42145780451 @default.
- W4214578045 hasLocation W42145780452 @default.
- W4214578045 hasLocation W42145780453 @default.
- W4214578045 hasOpenAccess W4214578045 @default.
- W4214578045 hasPrimaryLocation W42145780451 @default.
- W4214578045 hasRelatedWork W1722328147 @default.
- W4214578045 hasRelatedWork W1977009893 @default.
- W4214578045 hasRelatedWork W2050439103 @default.
- W4214578045 hasRelatedWork W2066747782 @default.
- W4214578045 hasRelatedWork W2593475799 @default.
- W4214578045 hasRelatedWork W2934076975 @default.
- W4214578045 hasRelatedWork W3029676034 @default.
- W4214578045 hasRelatedWork W3110327391 @default.
- W4214578045 hasRelatedWork W75229661 @default.
- W4214578045 hasRelatedWork W2342209702 @default.
- W4214578045 hasVolume "23" @default.
- W4214578045 isParatext "false" @default.
- W4214578045 isRetracted "false" @default.